SELLAS (SLS) Is On The Rise Pre-Market – Soar 68%
SELLAS Life Sciences Group Inc. (SLS) is a late-stage clinical biopharmaceutical company focusing on the production of innovative cancer immunotherapies for a wider variety of indications of cancer. And today, in absence of any significant news directly linked to the company, the company’s stock has been skyrocketing more than 67% in pre-market trades at a […]
